BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27604406)

  • 21. Developmental Outcomes of Aicardi Goutières Syndrome.
    Adang L; Gavazzi F; De Simone M; Fazzi E; Galli J; Koh J; Kramer-Golinkoff J; De Giorgis V; Orcesi S; Peer K; Ulrick N; Woidill S; Shults J; Vanderver A
    J Child Neurol; 2020 Jan; 35(1):7-16. PubMed ID: 31559893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aicardi-Goutières syndrome: unusual neuro-radiological manifestations.
    Abdel-Salam GMH; Abdel-Hamid MS; Mohammad SA; Abdel-Ghafar SF; Soliman DR; El-Bassyouni HT; Effat L; Zaki MS
    Metab Brain Dis; 2017 Jun; 32(3):679-683. PubMed ID: 28332073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutières syndrome-associated mutations.
    Goncalves A; Karayel E; Rice GI; Bennett KL; Crow YJ; Superti-Furga G; Bürckstümmer T
    Hum Mutat; 2012 Jul; 33(7):1116-22. PubMed ID: 22461318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and genetic analysis of a family with Aicardi-Goutières syndrome and literature review].
    Ji T; Wang J; Li H; Zhao L; Sang Y; Wu Y
    Zhonghua Er Ke Za Zhi; 2014 Nov; 52(11):822-7. PubMed ID: 25582466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple Autoimmune Disorders in Aicardi-Goutières Syndrome.
    Samanta D; Ramakrishnaiah R; Crary SE; Sukumaran S; Burrow TA
    Pediatr Neurol; 2019 Jul; 96():37-39. PubMed ID: 30898416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late-Onset Aicardi-Goutières Syndrome: A Characterization of Presenting Clinical Features.
    Piccoli C; Bronner N; Gavazzi F; Dubbs H; De Simone M; De Giorgis V; Orcesi S; Fazzi E; Galli J; Masnada S; Tonduti D; Varesio C; Vanderver A; Vossough A; Adang L
    Pediatr Neurol; 2021 Feb; 115():1-6. PubMed ID: 33307271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study.
    Rice GI; Forte GM; Szynkiewicz M; Chase DS; Aeby A; Abdel-Hamid MS; Ackroyd S; Allcock R; Bailey KM; Balottin U; Barnerias C; Bernard G; Bodemer C; Botella MP; Cereda C; Chandler KE; Dabydeen L; Dale RC; De Laet C; De Goede CG; Del Toro M; Effat L; Enamorado NN; Fazzi E; Gener B; Haldre M; Lin JP; Livingston JH; Lourenco CM; Marques W; Oades P; Peterson P; Rasmussen M; Roubertie A; Schmidt JL; Shalev SA; Simon R; Spiegel R; Swoboda KJ; Temtamy SA; Vassallo G; Vilain CN; Vogt J; Wermenbol V; Whitehouse WP; Soler D; Olivieri I; Orcesi S; Aglan MS; Zaki MS; Abdel-Salam GM; Vanderver A; Kisand K; Rozenberg F; Lebon P; Crow YJ
    Lancet Neurol; 2013 Dec; 12(12):1159-69. PubMed ID: 24183309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières Syndrome and Beyond.
    Livingston JH; Crow YJ
    Neuropediatrics; 2016 Dec; 47(6):355-360. PubMed ID: 27643693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-Stimulated Gene Expression as a Preferred Biomarker for Disease Activity in Aicardi-Goutières Syndrome.
    Wang BX; Grover SA; Kannu P; Yoon G; Laxer RM; Yeh EA; Fish EN
    J Interferon Cytokine Res; 2017 Apr; 37(4):147-152. PubMed ID: 28387595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early arteriopathy in Aicardi-Goutières syndrome 5. Case report and review of literature.
    Markovic I; Jocic-Jakubi B; Milenkovic Z
    Neuroradiol J; 2023 Dec; 36(6):740-745. PubMed ID: 36722173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of three induced pluripotent cell lines (iPSCs) from an Aicardi-Goutières syndrome (AGS) patient harboring a deletion in the genomic locus of the sterile alpha motif and HD domain containing protein 1 (SAMHD1).
    Fuchs NV; Schieck M; Neuenkirch M; Tondera C; Schmitz H; Wendeburg L; Steinemann D; Elpers C; Rutsch F; König R
    Stem Cell Res; 2020 Mar; 43():101697. PubMed ID: 32062129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A SAMHD1 mutation associated with Aicardi-Goutières syndrome uncouples the ability of SAMHD1 to restrict HIV-1 from its ability to downmodulate type I interferon in humans.
    White TE; Brandariz-Nuñez A; Martinez-Lopez A; Knowlton C; Lenzi G; Kim B; Ivanov D; Diaz-Griffero F
    Hum Mutat; 2017 Jun; 38(6):658-668. PubMed ID: 28229507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection.
    Berger A; Sommer AF; Zwarg J; Hamdorf M; Welzel K; Esly N; Panitz S; Reuter A; Ramos I; Jatiani A; Mulder LC; Fernandez-Sesma A; Rutsch F; Simon V; König R; Flory E
    PLoS Pathog; 2011 Dec; 7(12):e1002425. PubMed ID: 22174685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SAMHD1-deficient fibroblasts from Aicardi-Goutières Syndrome patients can escape senescence and accumulate mutations.
    Franzolin E; Coletta S; Ferraro P; Pontarin G; D'Aronco G; Stevanoni M; Palumbo E; Cagnin S; Bertoldi L; Feltrin E; Valle G; Russo A; Bianchi V; Rampazzo C
    FASEB J; 2020 Jan; 34(1):631-647. PubMed ID: 31914608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial Aicardi-Goutières syndrome due to SAMHD1 mutations is associated with chronic arthropathy and contractures.
    Dale RC; Gornall H; Singh-Grewal D; Alcausin M; Rice GI; Crow YJ
    Am J Med Genet A; 2010 Apr; 152A(4):938-42. PubMed ID: 20358604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of LINE-1 and Alu/SVA retrotransposition by Aicardi-Goutières syndrome-related SAMHD1.
    Zhao K; Du J; Han X; Goodier JL; Li P; Zhou X; Wei W; Evans SL; Li L; Zhang W; Cheung LE; Wang G; Kazazian HH; Yu XF
    Cell Rep; 2013 Sep; 4(6):1108-15. PubMed ID: 24035396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and neuroradiologic variability of Aicardi-Goutiéres syndrome: Two siblings with RNASEH2C mutation and a boy with TREX1 mutation.
    Uyur Yalçın E; Maraş Genç H; Kara B
    Turk J Pediatr; 2015; 57(5):504-8. PubMed ID: 27411419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A large homozygous deletion in the SAMHD1 gene causes atypical Aicardi-Goutiéres syndrome associated with mtDNA deletions.
    Leshinsky-Silver E; Malinger G; Ben-Sira L; Kidron D; Cohen S; Inbar S; Bezaleli T; Levine A; Vinkler C; Lev D; Lerman-Sagie T
    Eur J Hum Genet; 2011 Mar; 19(3):287-92. PubMed ID: 21102625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A clinical course of patient with Aicardi-Goutieres syndrome due to SAMHD1 gene abnormality].
    Watanabe E; Onozawa K; Fujita T; Tomonoh Y; Ihara Y; Yasumoto S; Nishikomori R; Heike T; Hirose S
    No To Hattatsu; 2017 Jan; 49(1):51-2. PubMed ID: 30011156
    [No Abstract]   [Full Text] [Related]  

  • 40. Aicardi-Goutières syndrome.
    Crow YJ
    Handb Clin Neurol; 2013; 113():1629-35. PubMed ID: 23622384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.